Anti-resorptive effect of pilose antler blood (cervus nippon temminck) in ovariectomized rats

Indian Journal of Experimental Biology

Volumn 48, Issue 6, 2010, Pages 554-558

  Yang, Jian Hong ^a,b   Cao, Yi ^b,c   Wang, Rui Lin ^b   Fei, Yu Rong ^b   Zhang, Hui ^b,d   Feng, Pu ^d   Liu, Jing ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Jiang university   (China)

^d TSINGHUA UNIVERSITY   (China)

Author keywords

17 estradiol; Bone mineral density; Insulin like growth factor 1; Osteoporosis; Pilose antler blood; Testosterone

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; ESTRADIOL; MATERIA MEDICA; OSTEOCALCIN; PHOSPHORUS;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; BONE DENSITY; CHEMISTRY; DRUG EFFECT; FEMALE; HORN; ISOLATION AND PURIFICATION; MALE; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; RAT; WISTAR RAT; DRUG EFFECTS;

ALKALINE PHOSPHATASE; ANIMALS; ANTLERS; BODY WEIGHT; BONE DENSITY; BONE RESORPTION; CALCIUM; ESTRADIOL; FEMALE; MALE; MATERIA MEDICA; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; PHOSPHORUS; RATS; RATS, WISTAR;

CERVUS NIPPON; RATTUS; RATTUS NORVEGICUS;

EID: 77954259595     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Gronholz M J, Prevention, diagnosis, and management of osteoporosis-related fracture: a multifactoral osteopathic approach, J Am Osteopath Assoc, 108 (2008) 575.
2. Doggrell S, Present and future pharmacotherapy for osteoporosis, Drugs Today, 39 (2003) 633.
3. Coldize G A, Hormone replacement therapy increases the risk of breast cancer, Ann NYAcad Sci, 833 (1997) 129.
4. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby L K, Waters D, Vittinghoff E & Wenger N, HERS research group. Cardiovascular disease outcomes during 6.8 years of hormone therapy, JAMA, 288 (2002) 49.
5. Sunwoo H H & Sim J S, Potential uses of velvet antler as nutraceuticals, functional and medical foods in the West, J Nut, Func & Med Foods, 2 (2000) 5.
6. Young K H, Jae J E, Young P Y & Hee K M, Effect of deer antler drink supplementation on blood pressure blood glucose and lymphocyte DNA damage in type 2 diabetic patients, Kore JNutr, 37 (2004) 794.
7. Zhou Q L, Guo Y J, Wang L J, Wang Y, Liu Y Q, Wang Y & Wang B X, Velvet antler polypeptides promoted proliferation of chondrocytes and osteoblast precursors and fracture healing, Ada Pharm Sin, 20 (1999) 279.
8. Kim K H, Kim K S, Chi B J, Chung K H, Chang Y C, Lee S D, Park K K, Kim H M & Kim C H, Anti-bone resorption activity of deer antler aqua-acupunture, the pilose antler of Cervus korean TEMMINCK var. mantchuricus Swinhoe (Nokyong) in adjuvant-induced arthritic rats, J Ethnopharmacol, 96 (2005) 497.
9. Nian H, Qin L P, Chen W S, Zhang Q Y, Zheng H C & Wang Y, Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-inducced bone loss in rats, Ada Pharm Sin, 27 (2006) 728.
10. Daughaday W H & Rotwein P, Insulin like growth factor I and II. Peptide, messenger ribonucleic acid and gene structure, serum and tissue concentrations, Endodin Rev, 10 (1989)68.
11. Fante P, Kindy M S, Mohapatra S, Klein J, Colombo G & Malluche H H, Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture, Am J Physiol, 263 (1992) El 113.
12. Simonet W S, Lacey D L, Dunstan C R, Kelley M, Chang M S, Lúfhi R, Nguyen H Q, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan H L, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes T M, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R & Boyle W J, Osteoprotegerin, a novel secreted protein involved in theregulation of bone density, Cell, 89 (1997) 309.
13. McCann D & Kirkish L, Evaluation of Free Testosterone in serum, J Clin Immunoassay, 8 (1985) 234.
14. Eriksen E F, Colvard D S, Berg N J, Graham M L, Mann K G, Spelsberg T C & Riggs B L, Evidence of estrogen receptors in normal human osteoblast-like cells, Science, 241 (1988) 84.
15. Bord S, Horner A, Beavan S & Compston J, Estrogen receptors alpha and beta are differentially expressed in developing human bone, J Clin Endocrinol Metab, 86 (2001) 2309.
16. Oreffo R O, Expression of estrogen receptor alpha in cells of osteoclastic lineage, Histochem Cell Biol, 111 (1999) 125.
17. Turner R T, Mice, estrogen, and postmenopausal osteoporosis, J Bone Miner Res, 14 (1999) 187.
18. Daci E, Verstuyf A, Moermans K, Bouillon R & Carmeliet G, Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency, J Bone Miner Res, 15 (2000) 1510.
19. Kalantaridou S N & Calis K A, Testosterone therapy in premenopausal women, Semin Reprod Med, 24(2006) 106.
20. Clarke B L & Khosla S, Androgens and bone, Steroids, 74 (2009) 296.
21. Eyre L J, Bland R, Bujalska I J, Sheppard M C, Stewart P M & Hewison M, Characterization of aromatase and 17-hydroxysteroid dehydrogenase expression in rat osteoblastic cells, J Bone Miner Res, 13 (1998) 996.
22. Shozu M & Simpson E R, Aromatase expression of human osteoblast-like cells, Mol Cell Endocrinol, 139 (1998) 117.
23. Seftel A, Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis, Int J Impot Res, 18 (2006) 223.
24. Vanderschueren D, Vandenput L, Boonen S, Lindberg M K, Bouilon R & Ohlsson C, Androgens and bone, Endocr Rev, 25 (2004) 389.
25. Giustina A, Mazziotti G & Canalis E, Growth hormone, insulin-like growth factors, and the skeleton, Endocr Rev, 29 (2008)535.
26. Yakar S & Rosen C J, From mouse to man: redefining the role of insulin-like growth factor-I in the acquisition of bone mass, Exp Biol Med (Maywood), 228 (2003) 245.
27. Chiarelli F, Giannini C & Mohn A, Growth, growth factors and diabetes, Eur J Endocrinol, 151 (2004) 109.
28. Ueland T, GH/IGF-I and bone resorption in vivo and in vitro, Eur J Endocrinol, 152 (2005) 327.
29. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C & Halloran B, The skeletal structure of IGF-I deficient mice, J Bone Miner Res, 16 (2001) 1320.
30. Miyakoshi N, Kasukawa Y, Linkhart T A, Baylink D J & Mohan S, Evidence that anabolic effects of PTH on bone require IGF-I in growing mice, Endocrinology, 142 (2001) 4349.
31. Camacho-Hubner C, Woods K A, Miraki-Moud F, Hindsmarsh P C, Clark A J, Hansson Y, Johnston A, Baxter R C & Savage M O, Effects of recombinant hIGF-I therapy on the GH/IGF system of a patient with a partial IGF-I gene deletion, J Clin Endocrino Metab, 84 (1999) 1611.
32. Zhao G, Monier-Faugere M C, Langub M C, Geng Z, Nakayama T, Pike J W, Chernausek S D, Rosen C J, Donahue L R, Malluche H H, Fagin J A & Clemens T L, Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation, Endocrinology, 141 (2000) 2674.
33. Jian G J, Gronowicz G, Ledgard F, Clark S H, Lichtler A C & Kream B E, Phenotypic characterization of transgenic mice with bone directed overexpression of IGF-I, J Bone Miner Res, 15 (2000) S157.